Den systemiske eksponering fra lokal anvendelse af tacrolimus er lav (< 1, 0 ng/ ml) og påvirkes næppe ved
Systemic exposure from topical application of tacrolimus ointment is low (< 1.0 ng/ ml) and is unlikely to be affected by concomitant use of substances known to be inhibitors of CYP3A4.